Elizabeth E Reed

SVP, GC & CORPORATE SECRETARY

Elizabeth E Reed (SVP, GC & CORPORATE SECRETARY) filed 9 Form 4 reports in the trailing twelve months (0 purchases, 9 sales), most often in Travere Therapeutics, Inc. (TVTX). The largest single filing was $2.2M of TVTX (35,800 sh across 2 lots, as filed), executed Sep 15.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 9 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$6.7M

shares × price, as filed

Last traded

Sep 15

Filed Sep 17

Median ADV $123.0M across their filed names

Open performance→

Volume by month

Buys $0 Sells $7.4M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 9 filings

Sector per market data · by filing · past 12 months

Most traded names

TVTX

Travere Therapeutics, Inc. TVTX · 0 buys · 12 sells 12 filings

Recent filings

TVTXSALE Travere Therapeutics, Inc. View filing → $2.2M
35,800 sh across 2 lots
Exec Sep 15
Filed Sep 17 · 9:32 PM ET TVTXSALE Travere Therapeutics, Inc. View filing → $1.0M
22,174 sh across 2 lots
Exec May 4
Filed May 6 · 5:30 PM ET TVTXSALE Travere Therapeutics, Inc. View filing → $2.1M
49,941 sh across 3 lots
Exec Apr 14
Filed Apr 15 · 5:30 PM ET TVTXSALE Travere Therapeutics, Inc. View filing → $300K
10,000 sh × $30.00
Exec Apr 1
Filed Apr 2 · 5:30 PM ET TVTXSALE Travere Therapeutics, Inc. View filing → $281K
10,000 sh × $28.09
Exec Mar 16
Filed Mar 18 · 5:30 PM ET TVTXSALE Travere Therapeutics, Inc. View filing → $278K
10,000 sh across 2 lots
Exec Feb 17
Filed Feb 19 · 5:30 PM ET TVTXSALE Travere Therapeutics, Inc. View filing → $230K
7,175 sh × $32.12
Exec Feb 3
Filed Feb 3 · 5:30 PM ET TVTXSALE Travere Therapeutics, Inc. View filing → $273K
10,000 sh × $27.34
Exec Jan 20
Filed Jan 21 · 5:30 PM ET More filings →